Skip to main content
Clinical Trials/NCT01091766
NCT01091766
Completed
Phase 4

Sensitivity of Electrocardiogram on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine: a Study in Children of Different Age

University Children's Hospital, Zurich1 site in 1 country150 target enrollmentMarch 2010

Overview

Phase
Phase 4
Intervention
intravenous injection of test solution
Conditions
Anaesthesia
Sponsor
University Children's Hospital, Zurich
Enrollment
150
Locations
1
Primary Endpoint
T-wave elevation in the ECG after intravenous administration of the test solution
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this prospective randomised study is to investigate electrocardiographic alterations after intravascular injection of three different test solutions of bupivacaine and epinephrine in anaesthetised children up to 16 years of age.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
July 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Children's Hospital, Zurich
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 0 to 16
  • parental consent

Exclusion Criteria

  • allergy against local anaesthetics

Arms & Interventions

bupivacaine

test solution consists of bupivacaine 0.125%

Intervention: intravenous injection of test solution

bupivacaine+epinephrine

test solution consists of bupivacaine 0.125% with epinephrine 1:200000

Intervention: intravenous injection of test solution

epinephrine

test solution consists of epinephrine 1:200000

Intervention: intravenous injection of test solution

Outcomes

Primary Outcomes

T-wave elevation in the ECG after intravenous administration of the test solution

Time Frame: 2 minutes

0.2 ml/kg test solution (bupivacaine or bupivacaine+epinephrine or epinephrine) is intravenously injected. The ECG is recorded over 2 minutes, printed and analysed later on regarding alterations of T-wave.

Secondary Outcomes

  • Alteration in heart rate caused by intravenous injection of the test solution(2 minutes)

Study Sites (1)

Loading locations...

Similar Trials